Nuveen Asset Management, LLC Macrogenics Inc Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Macrogenics Inc stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 198,470 shares of MGNX stock, worth $641,058. This represents 0.0% of its overall portfolio holdings.

Number of Shares

198,470

Previous 198,470 -0.0%

Holding current value

$641,058

Previous $843,000 22.66%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$3.31 - $18.51 $1.16 Million - $6.5 Million	-351,170 Reduced 63.89%	198,470 $843,000
Q1 2024 May 13, 2024	SELL	$9.77 - $21.47 $562,468 - $1.24 Million	-57,571 Reduced 9.48%	549,640 $8.09 Million
Q4 2023 Feb 14, 2024	SELL	$4.48 - $10.11 $1.47 Million - $3.31 Million	-327,770 Reduced 35.06%	607,211 $5.84 Million
Q3 2023 Nov 14, 2023	SELL	$4.48 - $6.19 $6,612 - $9,136	-1,476 Reduced 0.16%	934,981 $4.36 Million
Q2 2023 Aug 14, 2023	BUY	$4.62 - $7.54 $1.17 Million - $1.91 Million	252,840 Added 36.99%	936,457 $5.01 Million
Q1 2023 May 15, 2023	BUY	$4.82 - $7.24 $800,399 - $1.2 Million	166,058 Added 32.08%	683,617 $4.9 Million
Q4 2022 Feb 14, 2023	BUY	$3.34 - $6.98 $67,200 - $140,437	20,120 Added 4.04%	517,559 $3.47 Million
Q3 2022 Nov 14, 2022	BUY	$3.01 - $5.22 $513,551 - $890,610	170,615 Added 52.2%	497,439 $1.72 Million
Q2 2022 Aug 15, 2022	BUY	$2.25 - $9.99 $51,907 - $230,469	23,070 Added 7.59%	326,824 $965,000
Q1 2022 May 16, 2022	SELL	$8.12 - $16.9 $314,495 - $654,553	-38,731 Reduced 11.31%	303,754 $2.66 Million
Q4 2021 Feb 14, 2022	SELL	$15.91 - $21.88 $147,565 - $202,937	-9,275 Reduced 2.64%	342,485 $5.5 Million
Q3 2021 Nov 12, 2021	SELL	$19.74 - $28.7 $487,893 - $709,349	-24,716 Reduced 6.57%	351,760 $7.37 Million
Q2 2021 Aug 16, 2021	SELL	$20.49 - $35.63 $553,783 - $962,972	-27,027 Reduced 6.7%	376,476 $10.1 Million
Q1 2021 May 17, 2021	SELL	$18.99 - $33.2 $8.92 Million - $15.6 Million	-469,718 Reduced 53.79%	403,503 $12.9 Million
Q4 2020 May 17, 2021	SELL	$19.41 - $26.0 $319,410 - $427,856	-16,456 Reduced 1.85%	873,221 $20 Million
Q4 2020 Feb 16, 2021	SELL	$19.41 - $26.0 $44,448 - $59,540	-2,290 Reduced 0.26%	889,677 $20.3 Million
Q3 2020 Nov 16, 2020	BUY	$24.69 - $31.6 $3.14 Million - $4.02 Million	127,172 Added 16.63%	891,967 $6.78 Million
Q2 2020 Aug 14, 2020	SELL	$5.2 - $29.12 $659,152 - $3.69 Million	-126,760 Reduced 14.22%	764,795 $5.81 Million
Q1 2020 May 14, 2020	BUY	$4.28 - $12.11 $790,344 - $2.24 Million	184,660 Added 26.12%	891,555 $5.19 Million
Q4 2019 Feb 14, 2020	BUY	$7.95 - $12.27 $23,905 - $36,895	3,007 Added 0.43%	706,895 $7.69 Million
Q3 2019 Nov 14, 2019	SELL	$12.44 - $17.48 $1.18 Million - $1.66 Million	-95,235 Reduced 11.92%	703,888 $8.98 Million
Q2 2019 Aug 15, 2019	BUY	$14.51 - $19.71 $11.6 Million - $15.8 Million	799,123 New	799,123 $13.6 Million

Others Institutions Holding MGNX

# of Institutions

132

Shares Held

55.4M

Call Options Held

215K

Put Options Held

238K

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $199M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Macrogenics Inc Transaction History